Status:
COMPLETED
Observational Study of Safety and Efficacy of Levemir® in Type 2 Diabetes
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
6+ years
Brief Summary
The study is conducted in Asia. The aim of this observational study is to evaluate the weight change from baseline while using Levemir® in subjects with type 2 diabetes mellitus under normal clinical ...
Eligibility Criteria
Inclusion
- Any subject with type 2 diabetes
Exclusion
- Subjects with a hypersensitivity to insulin detemir or any of its excipient
- Children below 6 years
- Subjects who are pregnant, lactating or planning to become pregnant
Key Trial Info
Start Date :
April 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
10008 Patients enrolled
Trial Details
Trial ID
NCT00687063
Start Date
April 1 2008
End Date
February 1 2009
Last Update
November 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bangalore, India, 560001